Dark
Light
Today: July 22, 2024
December 18, 2023
1 min read

Top VCs Predict 2024 Takeoff for 25 Healthcare Startups

In a recent article, Business Insider spoke to top healthcare venture capitalists (VCs) and asked them to recommend healthcare startups which they believe will grow significantly in 2024. Notably, the VCs highlighted that their choices were held to high standards as healthcare-investment activity slows down. They each nominated a startup they had invested in as well those they had no financial ties with.

  • Aetion was picked by Lynne Chou O’Keefe, the founder and managing partner of Define Ventures. The company supplies pharmaceutical corporations, payers, and regulators with real-world evidence that can be used to make informed decisions.
  • Artisight was chosen by Morgan Cheatham, a vice president at Bessemer Venture Partners’ New York office. The firm uses computer vision to virtually monitor and collect data from hospital operations, freeing up nurses’ time.
  • Brightline provides behavioural healthcare to children and teenagers across all 50 states. It was chosen by AG Breitenstein, a partner at Define Ventures.
  • Caraway provides telehealth services for mental, physical, and reproductive health, specially designed for Generation Z patients. It was chosen by Alyssa Jaffee, an investor and partner at 7wireVentures, and Chrissy Farr, an investor and a principal at OMERS Ventures.
  • CareBridge works with Medicaid plans to organize in-home care for low-income patients with physical, intellectual, and developmental disabilities. Annie Lamont, an investor and a co-founder and managing partner of Oak HC/FT believes this company is set for significant growth in 2024.

Other startups nominated by the VCs include Cleerly, Cohere Health, Conceivable Life Sciences, ConcertAI, Cortica, Crescendo Health, Elaborate, Equip Health, Fortuna Health, Greater Good Health, Grow Therapy, Lyra Health, Maven Clinic, Midi Health, Oasis Health Partners, Plenful, RadiantGraph, Rippl, Slope Clinical, and Willow Health.

Previous Story

Sweetch Energy scores €25M to turbocharge worldwide osmotic energy revolution.

Next Story

Canada’s cleantech funding: Time for a SDTC fallout shake-up?

Latest from Blog

Antheia Secures $17M Investment

TLDR: Antheia, a pharmaceutical ingredient manufacturer based in Menlo Park, CA, raised $17M in funding. The funding included a non-dilutive two-year project agreement up to $11M through the BioMaP Consortium. Antheia, led
Go toTop